Target Discovery and Validation

Target discovery and validation is a key step in drug discovery, however, finding proper targets in related pathways can be challenging. Combining genomics/genome sequencing platform with sophisticated cell analysis, Creative Biolabs is able to quickly identify targets in virtually any biological matrix, nominally cell cultures, tissues or body fluids. Our target discovery services can help researchers who are practicing in the field such as breast cancer, melanoma, lung cancer, sarcomas, hematologic malignancies and others.

You are likely to benefit if you are looking to:

• Identify a therapeutic agent for a particular disease or condition that does not have a treatment currently.
• Discover or validate drug targets that may be novel, presumed, or identified at the stage.
• Discover or validate new high-quality targets for common protein targets, including enzymes, cell signaling receptors, structural proteins and regulatory factors such as protein kinases.
• Finding other emerging targets include nucleic acids such as mRNA, lipids and carbohydrates.

One-stop Target Discovery and Validation Services

Creative Biolabs has developed an innovative phenotypic screening platform to update on the technology portfolio we currently serve. In the target-based screening, we are able to validate candidate target by combining a number of experimental methods, such as high-content screening, high-throughput gene expression analysis and human primary cell-based assays and some others. Using our AI-related systems, we can further validate the functions of disease targets and, hopefully, explain how the target modulations possess therapeutic effects.

Our expertise on extensive analysis, reagents identification and library combination skills can surely facilitate the identification and validation of novel targets you are looking for.

Please feel free to contact us for more detailed information.